Anti-Drug Antibodies as Prognostic Indicators for Treatment Discontinuation in Inflammatory Bowel Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Alimentary Pharmacology & Therapeutics
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Early Detection of Anti-Drug Antibodies During Initiation of Anti-Tumour Necrosis Factor Therapy Predicts Treatment Discontinuation in Inflammatory Bowel Disease
Aliment. Pharmacol. Ther. 2021 Jun 01;53(11)1190-1200, Q Tournier, S Paul, N Williet, AE Berger, P Veyrard, G Boschetti, B Le Roy, M Killian, JM Phelip, B Flourie, S Nancey, X RoblinFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.